Related Experiment Video

Updated: Jun 4, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K

The Challenges in Treating Inflammatory Bowel Diseases During the COVID-19 Pandemic: An Opinion

Jonatan Vukovic1,2, Ivana Jukic1,3, Ante Tonkic1,2

  • 1Department of Gastroenterology and Hepatology, Internal Clinic, Clinical Hospital Centre Split, Spinciceva 1, 21000 Split, Croatia.

Journal of Clinical Medicine
|December 17, 2024
PubMed

Insights

The COVID-19 pandemic complicated inflammatory bowel disease (IBD) treatment, affecting routine care and immunosuppressive therapy safety. Strategies are explored to manage IBD during this global health crisis.

Area of Science:

  • Gastroenterology and Immunology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted healthcare systems globally.
  • Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, require ongoing management.
  • Patients with IBD often require immunosuppressive therapies, raising concerns during viral pandemics.

Purpose of the Study:

  • To explore the challenges in managing inflammatory bowel diseases (IBD) during the COVID-19 pandemic.
  • To discuss the multifaceted obstacles faced in IBD treatment during the pandemic.
  • To identify and discuss potential strategies for overcoming these challenges.

Main Methods:

  • This article is a review and discussion of challenges and strategies.
  • It synthesizes information regarding IBD care disruptions.
  • It examines concerns related to immunosuppression and COVID-19 infection in IBD patients.

Main Results:

  • Routine IBD care faced significant disruptions.
  • Concerns regarding the safety of immunosuppressive medications were heightened.
  • Managing IBD patients who contracted COVID-19 presented unique complexities.

Conclusions:

  • The COVID-19 pandemic created substantial hurdles in IBD management.
  • Addressing these challenges requires adaptive strategies in healthcare delivery and patient monitoring.
  • Continued research and collaboration are essential for optimizing IBD care during public health emergencies.

Keywords:
COVID-19Crohn’s diseaseSARS-CoV-2 infectionhealthcare challengesinflammatory bowel diseasespandemictreatmentulcerative colitis

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

3.8K
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

19.4K

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
111
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
116
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183